ACLX
Price
$66.25
Change
+$0.77 (+1.18%)
Updated
Jun 5 closing price
Capitalization
3.61B
73 days until earnings call
CYTK
Price
$32.08
Change
-$0.33 (-1.02%)
Updated
Jun 5 closing price
Capitalization
3.83B
55 days until earnings call
Interact to see
Advertisement

ACLX vs CYTK

Header iconACLX vs CYTK Comparison
Open Charts ACLX vs CYTKBanner chart's image
Arcellx
Price$66.25
Change+$0.77 (+1.18%)
Volume$435.52K
Capitalization3.61B
Cytokinetics
Price$32.08
Change-$0.33 (-1.02%)
Volume$1.02M
Capitalization3.83B
ACLX vs CYTK Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. CYTK commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and CYTK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ACLX: $66.25 vs. CYTK: $32.08)
Brand notoriety: ACLX and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 53% vs. CYTK: 46%
Market capitalization -- ACLX: $3.61B vs. CYTK: $3.83B
ACLX [@Biotechnology] is valued at $3.61B. CYTK’s [@Biotechnology] market capitalization is $3.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 7 TA indicator(s) are bullish while CYTK’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 7 bullish, 2 bearish.
  • CYTK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than CYTK.

Price Growth

ACLX (@Biotechnology) experienced а +4.04% price change this week, while CYTK (@Biotechnology) price change was +2.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 18, 2025.

CYTK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($3.83B) has a higher market cap than ACLX($3.61B). ACLX YTD gains are higher at: -13.613 vs. CYTK (-31.803). ACLX has higher annual earnings (EBITDA): -153.96M vs. CYTK (-513.62M). CYTK has more cash in the bank: 938M vs. ACLX (543M). ACLX has less debt than CYTK: ACLX (53.2M) vs CYTK (791M). ACLX has higher revenues than CYTK: ACLX (76.8M) vs CYTK (19.2M).
ACLXCYTKACLX / CYTK
Capitalization3.61B3.83B94%
EBITDA-153.96M-513.62M30%
Gain YTD-13.613-31.80343%
P/E RatioN/AN/A-
Revenue76.8M19.2M400%
Total Cash543M938M58%
Total Debt53.2M791M7%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXCYTK
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 9 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VITSX142.83N/A
N/A
Vanguard Total Stock Market Idx I
FSANX16.22N/A
N/A
Fidelity Asset Manager 60%
MSVYX17.47N/A
N/A
MassMutual Small Cap Opps Svc
AVEWX21.36N/A
N/A
Ave Maria World Equity
CDHAX33.79N/A
N/A
Calvert International Responsible Idx A

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+1.18%
CGON - ACLX
57%
Loosely correlated
+0.23%
KRYS - ACLX
56%
Loosely correlated
+0.53%
RNA - ACLX
55%
Loosely correlated
+4.00%
BEAM - ACLX
54%
Loosely correlated
-0.87%
XNCR - ACLX
53%
Loosely correlated
+0.22%
More

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with KRYS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-1.02%
KRYS - CYTK
47%
Loosely correlated
+0.53%
IDYA - CYTK
47%
Loosely correlated
-0.09%
TRDA - CYTK
44%
Loosely correlated
+2.14%
ACLX - CYTK
44%
Loosely correlated
+1.18%
ROIV - CYTK
44%
Loosely correlated
-0.18%
More